Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 11—November 2003

West Nile Virus Infection in Nonhuman Primate Breeding Colony, Concurrent with Human Epidemic, Southern Louisiana

Marion S. Ratterree*, Amelia P.A. Travassos da Rosa†, Rudolf P. Bohm*, Frank B. Cogswell*, Kathrine M. Phillippi*, Kevin Caillouet‡, Shelle Schwanberger*, Robert E. Shope†, and Robert B. Tesh†Comments to Author 
Author affiliations: *Tulane National Primate Research Center, Covington, Louisiana, USA; †University of Texas Medical Branch, Galveston, Texas, USA; ‡Tulane University, New Orleans, Louisiana, USA

Main Article

Table 3

Results of complement-fixation (CF) and plaque reduction neutralization (PRNT) tests done on sera of eight WNV-seropositive rhesus macaques bled in August 2002 at the Tulane National Primate Research Centera

Animal no. CF antibody titer
DENV-1 DENV-2 YFV SLEV WNV PRNT antibody titer with WNV
CK62 0 0 0 16/8b 128/>32 1:320c
CL07 0 0 0 8/8 64/>32 1:160
CL11 0 0 0 8/8 64/>32 1:1280
CL80 0 0 0 16/8 128/>32 1:80
CL93 0 0 0 32/8 128/>32 1:320
CM11 0 0 0 0 16/>32 1:160
CP90 0 0 0 0 32/>32 1:160
CR36 0 0 0 8/8 64/>32 1:320

aViral antigens used in CF test: DENV, dengue virus; YFV, yellow fever virus; SLEV, St. Louis encephalitis virus; WNV, West Nile virus.
bCF titers expressed as reciprocal of highest antibody titer/reciprocal of antigen titer.
cPRN titers expressed as highest serum dilution producing >90% plaque reduction.

Main Article

Page created: April 20, 2012
Page updated: April 20, 2012
Page reviewed: April 20, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.